Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
David Cade Elected as Board Chair Elect for National Contract Management Association
-
Form 8.3 - AXA INVESTMENT MANAGERS: Aviva plc
-
EMA Webinar to Explore How AI is Revolutionizing IT Operations
-
Options and Data Intellect Announce Partnership to Drive Innovation in Financial Data and Cloud Services
-
Attensi Named in Fast Company's Annual List of the World's Most Innovative Companies of 2025
-
Alto Ingredients, Inc. Directors to Not Stand for Reelection
-
Exubrion Therapeutics® Appoints Jennifer Kirk to Board of Directors; Names Her CEO
-
BV Investment Partners Ranks Top 10 in 2024 HEC-Paris Dow Jones Mid-Market Buyout Performance Ranking
-
Source Elements announces Source-Connect 4
-
Kiwi Mouse Trap Ranked Among World's Most Innovative Products
-
Intellicheck To Present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference
-
Ingram Micro’s Xvantage Integrations Hub Delivers a Plug-and-Play Experience, Virtually Eliminating the Complexity of Software Integrations
-
Q4 Wins in 2025 Stevie Awards for Sales & Customer Service
-
KORREKTIONSMEDDELELSE: Aktietilbagekøb i PARKEN Sport & Entertainment A/S: Transaktioner i uge 11
-
Apollo Health and Trifecta Nutrition Exclusively Partner to Bring Brain Healthy KetoFLEX 12/3 Nutrition Delivered Directly to Your Door
-
Yamaha Marine Donates XTO Offshore Outboards to High-Performing Technical Schools
-
Strategy Announces Proposed STRF Perpetual Preferred Stock Offering
-
J.S. Held Recognized Among Global Leaders in Enterprise Risk Management
-
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy
-
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post
-
Delinea Nears $400M, Demonstrating Strong Growth In Securing AI with Advanced Identity Security
-
Landsbankinn hf.: Covered bond exchange offering results
-
-
Surety One, Inc. Supporting Youth Achievement
-
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
-
Hill International Appointed as PMO Leader for Athens International Airport’s Airport Expansion Program
-
Spring Health Launches Neurodiversity Hub to Support Employees, Families, and Leaders
-
Ovation Mental Health Partners with Tennessee School of Beauty to Provide Comprehensive Mental Health Services
-
Aiosyn and Pramana Introduce Real-Time AI Processing for Kidney Biopsy Assessments
-
Wolters Kluwer expert on Community Reinvestment Act to speak at CBA LIVE national banking conference
-
KISS Products Unveils Exclusive WICKED-Inspired Nail and Lash Collections
-
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
-
CHO Plus Obtains U.S. Patent for Improved Production of Viral Vectors for Gene Therapy
-
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $
-
New Report Highlights 100+ Actionable Strategies for Climate-Resilient Water and Sanitation in Frontline Communities Across US
-
Buxton Takes Next Step in Revolutionizing Consumer Insights with Acquisition of Audiense
-
StepStone Group Announces 2025 Partner and Managing Director Promotions
-
Cytrellis Secures Health Canada and Saudi Food and Drug Authority Approval for ellacor® with Micro-Coring® Technology
-
Foresight Announces the Integration of NVIDIA Jetson Orin into its 3D Perception Systems
-
Europe’s Largest B2B Cannabis Conference Returns to Berlin in April 2025
-
New Research: 97% of Executives Feel Pressure to Maximize Revenue in the Next Two Years or They Risk Significant Consequences that Could Impact Bottom Lines
-
Madison Scientific Closes $7M in Seed Financing
-
Supply & Demand Chain Executive Honors LogicSource Leader, Erik Given, in the 2025 Pros to Know Awards
-
Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now receiv
-
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
-
Carhartt Unveils Inaugural "Steel Apple" Awards Celebrating Skilled Trades Educators Across America
-
Ankle & Foot Centers of America Offers Advanced Treatment Options for Fungal Toenail Infections
-
TPT Global Tech Super App Vume Live Announces Global Live Streams of Sports, News, and Entertainment Content
-
Labor Smart Inc. Expands Go Fast Energy with Q2 Direct-to-Consumer Growth Strategy
-
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
